The renin-angiotensin system and compensatory renal hypertrophy in the rat

American Journal of Hypertension

Volumn 10, Issue 4 I, 1997, Pages 397-402

  Valentin, Jean Pierre ^a,b   Sechi, Leonardo A ^a,c   Griffin, Chandi A ^a   Humphreys, Michael H ^a,d   Schambelan, Morris ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^c UNIVERSITY OF UDINE   (Italy)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

angiotensin converting enzyme inhibition; angiotensin II; angiotensin receptor antagonists; angiotensinogen mRNA; AT1 receptor; captopril; hypertrophy; kidney; renin mRNA; uninephrectomy

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; CAPTOPRIL; MESSENGER RNA; RENIN;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; DIURESIS; FLUID INTAKE; KIDNEY HYPERTROPHY; KIDNEY SURGERY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; HYPERTROPHY; KIDNEY; MALE; NEPHRECTOMY; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; RENIN-ANGIOTENSIN SYSTEM;

EID: 0031002292     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00447-5     Document Type: Article

References (42)

1. Fine LG: The biology of renal hypertrophy. Kidney Int 1986;29:619-634.
2. Wasson LG: Compensatory growth and other growth responses of the kidney. Nephron 1989;51:149-184.
3. Fine LG, Norman J: Cellular events in renal hypertrophy. Annu Rev Physiol 1992;51:19-32.
4. Schlondorff D, Weber H: Cyclic nucleotide metabolism in compensatory renal hypertrophy and neonatal kidney growth. Proc Natl Acad Sci USA 1976;73:524-528.
5. Toback FG, Smith PD, Lowenstein LM: Phospholipid metabolism in the initiation of renal compensatory growth after acute reduction of renal mass. J Clin Invest 1974;54:91-97.
6. Caramelo C, Tsai P, Okada K, Schrier RW: Protein kinase C activity in compensatory kidney growth. Biochem Biophys Res Comm 1988;152:315-321.
7. Hise MK, Mehta PS: Activity of calcium-sensitive phospholipid-dependent protein kinase C following nephron loss. Kidney Int 1989;36:216-221.
8. Humphreys MH, Etheredge SB, Lin SY, et al: Renal ornithine decarboxylase activity, polyamines, and compensatory renal hypertrophy in the rat. Am J Physiol 1988;255:F270-F277.
9. Oulette AJ, Moonka R, Zelenetz AD, Malt RD: Regulation of ribosome synthesis during compensatory renal hypertrophy in mice. Am J Physiol 1987;253:C506-C513.
10. Norman JT, Bohman RE, Fischmann G, et al: Patterns of mRNA expression during early cell growth differ in kidney epithelial cells destined to undergo compensatory hypertrophy versus regenerative hyperplasia. Proc Natl Acad Sci USA 1988;85:6768-6772.
11. Beer DG, Zweifel KA, Simpson DP, Pitot HC: Specific gene expression during compensatory renal hypertrophy in the rat. J Cell Physiol 1987;131:29-35.
12. Douglas JG: Angiotensin receptor subtypes of the kidney cortex. Am J Physiol 1987;253:F1-F7.
13. Ray PE, Aguilera G, Kopp JB, et al: Angiotensin II receptor mediated proliferation of cultured human fetal mesangial cells. Kidney Int 1991;40:764-771.
14. Re E, Rovigatti U: New approaches to the study of the cellular biology of the cardiovascular system. Circulation 1988;77(suppl I):114-117.
15. Norman J, Badie-Dezfooly B, Nord EP, et al: EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol 1987;253:F299-F309.
16. Norman JY: The role of angiotensin II in renal growth. Renal Physiol Biochem 1991;14:175-185.
17. Fogo A, Yoshida Y, Yared A, Ichikawa I: Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kindneys. Kidney Int 1990;38:1068-1074.
18. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993;3:1531-1540.
19. Baker KM, Booz GW, Dostal DE: Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992;54:227-241.
20. Valentin JP, Qiu C, Muldowney WP, et al: Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome. J Clin Invest 1992; 90:1302-1312.
21. Chirgwin JM, Przbyla AE, McDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18:5294-5299.
22. Sechi LA, Griffin CA, Grady EF, et al: Tissue-specific transcriptional regulation of insulin receptor gene in rats with strePtozotocin-induced diabetes mellitus. Diabetes 1992;41:1113-1118.
23. Murphy TJ, Alexander RW, Griendling KK, et al: Isolation of a cDNA encoding the type-1 angiotensin II receptor. Nature 1991;351:233-236.
24. Kalinyak JE, Perlman AJ: Tissue-specific regulation of angiotensinogen mRNA accumulation by dexamethasone. J Biol Chem 1987;262:460-464.
25. Kalinyak JE, Sochi LA, Griffin CA, et al: The reninangiotensin system in streptozotocin-induced diabetes in the rat. J Am Soc Nephrol 1993;4:1337-1345.
26. Sechi LA, Griffin CA, Schambelan M: Cardiac reninangiotensin system in streptozotocin-induced diabetes in the rat. Diabetes 1994;43:1180-1184.
27. Mendelsohn FAO, Millan M, Quinion R, et al: Localization of angiotensin II receptors in rat and monkey kidney by in vitro autoradiography. Kidney Int 1987; 31(suppl 20):S40-S44.
28. Sechi LA, Grady EF, Griffin CA, et al: Distribution of angiotensin II receptors subtypes in rat and human kidney. Am J Physiol 1992;262.F236-F240.
29. Anderson PW, Do YS, Hsueh W; Angiotensin II causes mesangial cell hypertrophy. Hypertension 1993;21:29-35.
30. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 1990;259:F768-F777.
31. Rosenberg ME, Chmielewski D, Hostetter TH: Effect of dietary protein on rat renin and angiotensinogen gene expression. J Clin Invest 1990;85:1144-1149.
32. Whiteside CI, Thompson J: The role of angiotensin II in progressive diabetic glomerulopathy in the rat. Endocrinology 1989;125:1932-1940.
33. Beukers JJB, Van Der Wal A, Hoedemarker PJ, Weening JJ: Converting enzyme inhibition and progressive glomerulosclerosis in the rat. Kidney Int 1987;32:794-800.
34. Anderson S, Rennke, HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.
35. Cartwright ME, Jaenke RS: Effects of dietary protein and captopril on glomerular permselectivity in rats with unilateral nephrectomy. Lab Invest 1988;59:492-499.
36. Wolf G, Mueller E, Stahl RAK, Ziyadeh F: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993;92:1366-1372.
37. Kujubu DA, Normal JT, Herschman HR, et al: Primary response gene expression in renal hypertrophy and hyperplasia: evidence for different growth initiation processes. Am J Physiol 1991;260:F823-F827.
38. Oulette AJ, Malt RA, Sukhatme VP, Bonventre JV: Expression of two immediate early genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. J Clin Invest 1990;85:766-771.
39. Nakamura T, Ebihara I, Tomino Y, et al: Gene expression of growth-related proteins and ECM constituents in response to unilateral nephrectomy. Am J Physiol 1992;262:F389-F396.
40. Gomez RA, Lynch KR, Chevalier RL, et al: Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol 1988; 254:F900-F906.
41. Wight JP, Basset AH, Le Carpentier JE, El Nahas AM: Effect of treatment with enalapril, verapamil and indomethacin on compensatory renal growth in the rat Nephrol Dial Transplant 1990;5:777-780.
42. Dworkin LD, Grosser M, Feiner HD, et al: Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney Int 1989;35:790-798.